Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 13/20 | 0.54 |
| ▸ | FBP1 | P09467 | 5/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL957409 | 0.81 | CA2 (0.50) | CA2FBP1 | |
| SCHEMBL9424519 | 0.75 | NPC1 (0.43) | CA2FBP1MEN1KMT2AALDH1A1 | |
| SCHEMBL2242111 | 0.74 | ALDH1A1 (0.38) | CA2FBP1MEN1KMT2AALDH1A1 | |
| SCHEMBL2089671 | 0.72 | FBP1 (0.47) | CA2FBP1 | |
| SCHEMBL2087547 | 0.71 | FBP1 (0.45) | CA2FBP1 | |
| SCHEMBL10368859 | 0.71 | CA2 (1.00) | CA2 | |
| SCHEMBL22638715 | 0.67 | CA2 (0.41) | CA2MEN1KMT2AALDH1A1 | |
| SCHEMBL10388063 | 0.66 | CA2 (0.54) | CA2 | |
| SCHEMBL958207 | 0.65 | CA2 (0.46) | CA2FBP1 | |
| SCHEMBL10388054 | 0.65 | CA2 (0.43) | CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11506976-B2 | Radiation-sensitive composition and resist pattern-forming method | JSR CORPORATION (JP) | 2022-11-22 | — | — | US | disclosed |
| EP-3667419-A1 | RADIATION SENSITIVE COMPOSITION AND RESIST PATTERN FORMING METHOD | JSR Corporation (JP) | 2020-06-17 | — | — | EP | disclosed |
| US-20200166840-A1 | RADIATION-SENSITIVE COMPOSITION AND RESIST PATTERN-FORMING METHOD | JSR CORPORATION (JP) | 2020-05-28 | — | — | US | disclosed |
| EP-2512979-A2 | HYDROGEN STORAGE AND/OR GENERATION | California Institute of Technology (US) | 2012-10-24 | — | — | EP | disclosed |
| US-20110171119-A1 | HYDROGEN STORAGE AND/OR GENERATION | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 2011-07-14 | — | — | US | disclosed |
| WO-2011081949-A2 | HYDROGEN STORAGE AND/OR GENERATION | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2011-07-07 | — | — | WO | disclosed |
| US-7973051-B2 | Aminothiazoles as FBPase inhibitors for diabetes | HOFFMAN-LA ROCHE INC. (US) | 2011-07-05 | — | — | US | disclosed |
| EP-2227468-A1 | AMINOTHIAZOLE DERIVATIVES | F. Hoffmann-La Roche AG (CH) | 2010-09-15 | — | — | EP | disclosed |
| US-20090143448-A1 | NEW AMINOTHIAZOLES AS FBPASE INHIBITORS FOR DIABETES | F. HOFFMANN-LA ROCHE AG (CH) | 2009-06-04 | — | — | US | disclosed |
| WO-2009068467-A1 | AMINOTHIAZOLE DERIVATIVES | F. HOFFMANN-LA ROCHE AG (CH) | 2009-06-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090143448-A1 | NEW AMINOTHIAZOLES AS FBPASE INHIBITORS FOR DIABETES | FBP1, SLC5A1, DPP4 | CA2 1616/4885FBP1 1/4885MEN1 1402/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.